TN2011000038A1 - Nitrogenated derivatives of pancratistatin - Google Patents

Nitrogenated derivatives of pancratistatin

Info

Publication number
TN2011000038A1
TN2011000038A1 TN2011000038A TN2011000038A TN2011000038A1 TN 2011000038 A1 TN2011000038 A1 TN 2011000038A1 TN 2011000038 A TN2011000038 A TN 2011000038A TN 2011000038 A TN2011000038 A TN 2011000038A TN 2011000038 A1 TN2011000038 A1 TN 2011000038A1
Authority
TN
Tunisia
Prior art keywords
pancratistatin
nitrogenated
derivatives
nitrogenated derivatives
well
Prior art date
Application number
TN2011000038A
Other languages
French (fr)
Inventor
Frederic Marion
Jean-Philippe Annereau
Jacques Fahy
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/059715 external-priority patent/WO2010012714A1/en
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2011000038A1 publication Critical patent/TN2011000038A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention concerns nitrogenated derivatives of narciclasine and pancratistatin of the following general formula (I) as well as their pharmaceutically acceptable salts. The present invention also concerns the use of these compounds in cancer therapy as well as a method for their preparation.
TN2011000038A 2009-07-28 2011-01-26 Nitrogenated derivatives of pancratistatin TN2011000038A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/059715 WO2010012714A1 (en) 2008-07-28 2009-07-28 Nitrogenated derivatives of pancratistatin

Publications (1)

Publication Number Publication Date
TN2011000038A1 true TN2011000038A1 (en) 2012-09-05

Family

ID=55024352

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000038A TN2011000038A1 (en) 2009-07-28 2011-01-26 Nitrogenated derivatives of pancratistatin

Country Status (1)

Country Link
TN (1) TN2011000038A1 (en)

Similar Documents

Publication Publication Date Title
SA515360469B1 (en) Heterocyclic compounds for inhibiting glutaminase and their methods of use
TN2012000622A1 (en) Combinations of kinase inhibitors for the treatment of cancer
MX2013011332A (en) Combinations of akt inhibitor compounds and vemurafenib, and methods of use.
EA201100971A1 (en) DERIVATIVES OF PYRIMIDININDOL FOR THE TREATMENT OF MALIGNANT NORMALIZATION
MX2009009786A (en) Inhibitors of the hedgehog pathway.
MX2014012695A (en) Isoindolone derivatives.
PH12014501542B1 (en) Substituted pyrrolidine -2- carboxamides
PT2139484E (en) Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
UA115320C2 (en) Kinase inhibitors
MX2011009796A (en) Inhibitors of pi3 kinase.
MX2015017201A (en) Pyrazolopyridine derivatives for use in the treatment of bladder cancer.
JO3115B1 (en) Pyridazinone Compounds and Their Use as DAAO Inhibitors
MX2012002705A (en) Substituted xanthine derivatives.
MX2011011083A (en) Heterocyclic compounds as mek inhibitors.
CR20200286A (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
MX2013012588A (en) Kinase inhibitors.
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
MX2014003376A (en) Benzoic acid derivatives as eif4e inhibitors.
GB201209587D0 (en) Therapeutic compounds
IN2012DN01642A (en)
MX2013008340A (en) Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer.
PH12015500111A1 (en) Difluorolactam compositions for ep4-mediated osteo related diseases and conditions
JO3145B1 (en) Compounds useful for inhibiting chk1
IN2012DN02816A (en)
PH12015500399A1 (en) Azaindolines